Chest Disease Institute (CDI), Ministry of Public Health, Nonthaburi Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2008
NCT00864383
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5